CORC

在结果中检索

CORC

浏览/检索结果: 共230条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Observation of large-scale anisotropy in the arrival directions of cosmic rays with LHAASO-KM2A 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Gao, Wei;  Cao, Qing;  Chen, Songzhan;  Cui, Shuwang;  He, Huihai
收藏  |  浏览/下载：21/0  |  提交时间：2023/01/16
Search for very high energy γ-ray emission from GRB 190829A with LHAASO-WCDA triggerless data 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Yao, Yuhua;  Liu, Wei;  Qiao, Bingqiang;  Guo, Yiqing;  Hu, Hongbo
收藏  |  浏览/下载：21/0  |  提交时间：2023/01/16
Design and expected performances of the large acceptance calorimeter for the HERD space mission 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Pacini, Lorenzo;  Adriani, Oscar;  Bai, Yong-Lin;  Bao, Tian-Wei;  Berti, Eugenio
收藏  |  浏览/下载：44/0  |  提交时间：2022/12/30
An improved particle swarm optimization algorithm and its application on distribution generation accessing to distribution network 会议论文
Shanghai, China, May 24, 2019 - May 26, 2019
作者:  Wei, Zheng;  Yong, Zhi;  Chen, Liang;  Lei, Gao;  Wenpei, Zhu
收藏  |  浏览/下载：0/0  |  提交时间：2020/11/15
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：48/0  |  提交时间：2019/12/05
Prognosis assessment of acute-on-chronic liver failure in patients with hepatitis B virus-related cirrhosis requires specific criteria 会议论文
作者:  Gu Wenyi;  Deng, Guohong;  Zheng, Xin;  Chen, Jinjun;  Wang, Xian-bo
收藏  |  浏览/下载：90/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：40/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：33/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：31/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace